 SALT LAKE CITY , Dec. 20, 2022 PRNewswire -- Recursion NASDAQ: RXRX, the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following investor conferences: 41st Annual J.P. Morgan Healthcare Conference January 9 through January 12, 2023 25th Annual Needham Growth Conference January 10 through January 12, 2023 About Recursion Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. 